Skip to main content
Neuca S.A. logo

Neuca S.A. — Investor Relations & Filings

Ticker · NEU ISIN · PLTRFRM00018 LEI · 259400KFX90IZ97UDQ91 WAR Wholesale and retail trade
Open in API
Filings indexed 1,572 across all filing types
Latest filing 2018-04-09 M&A Activity
Country PL Poland
Listing WAR NEU

About Neuca S.A.

https://www.neuca.pl/s/?language=en_GB

Neuca S.A. is a leader in the wholesale distribution of pharmaceuticals, operating as a comprehensive partner in the healthcare market. The company's core business involves supplying medicines to pharmacies. A key strategic principle is not owning any pharmacies, a conscious decision to avoid competing with its primary clients. Instead, the company focuses on supporting its strategic partners—independent pharmacists—by providing a range of tools and services designed to build their competitiveness and profitability. In addition to its primary distribution activities, the group is also engaged in the manufacturing of pharmaceuticals and the management of clinical trials through its specialized subsidiaries, offering a broad portfolio of services across the healthcare value chain.

Recent filings

Filing Released Lang Actions
Zawiadomienie o połączeniu NEUCA S.A. z HA Galenica-Panax Sp. z o.o. i Unna Sp. z o.o.
M&A Activity Classification · 98% confidence The document is a formal notification from NEUCA S.A. to its shareholders regarding the intended merger (połączenie) of NEUCA S.A. (acquiring company) with two subsidiaries (UNNA sp. z o.o. and HURTOWNIA APTEKARZY "GALENICA-PANAX" sp. z o.o.). It explicitly cites Polish Commercial Companies Code articles (KSH) related to mergers (Art. 504, Art. 492, Art. 515). This type of corporate restructuring announcement, detailing a merger proposal, falls under the category of M&A Activity (Merger or Takeover Bid). The Polish legal basis cited (Art. 56 ust. 1 ust. 2 Ustawy o ofercie - raporty bieżące i okresowe) confirms it is a mandatory regulatory disclosure concerning a significant corporate transaction, which aligns best with the M&A Activity definition (TAR).
2018-04-09 Polish
Zawiadomienie o zamiarze połączenia NEUCA S.A. (jako spółki przejmującej) ze spółkami HA Galenica-Panax Sp. z o.o. oraz Unna Sp. z o.o. (jako spółki przejmowane) - Content (PL)
M&A Activity Classification · 98% confidence The document text, written in Polish, announces the intention of NEUCA S.A. (the acquiring company) to merge with two other entities (Hurtownia Aptekarzy Galenica-Panax Sp. z o.o. and Unna Sp. z o.o.). This action directly relates to a merger proposal or takeover bid, which falls under the definition of M&A Activity. The filing type code corresponding to M&A Activity is TAR.
2018-04-09 Polish
Nabycie spółki realizującej badania kliniczne - Content (PL)
M&A Activity Classification · 98% confidence The document text, written in Polish, announces that NEUCA S.A. acquired 100% of the shares of Clinmed Pharma Sp. z o.o. on April 6, 2018. This transaction involves the acquisition of another company, which falls under Merger & Acquisition (M&A) activity. Based on the provided definitions, the appropriate code is TAR (M&A Activity). The document is short and describes the transaction details, not just announcing the publication of a report.
2018-04-09 Polish
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 98% confidence The document text explicitly states that the company ('Spółka') acquired its own shares ('nabyła 971 akcji własnych') for the purpose of cancellation ('w celu umorzenia'). It details the number of shares acquired, the price, and the resulting percentage of the share capital held as treasury stock. This action directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2018-04-09 Polish
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 98% confidence The document text explicitly states that the Management Board ('Zarząd') of NEUCA S.A. acquired 60 of its own shares ('nabyła 60 akcji własnych') for the purpose of cancellation ('w celu umorzenia'). It details the price, nominal value, and the resulting percentage of total capital and voting rights held in treasury shares. This action directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). This matches the 'Transaction in Own Shares' category.
2018-04-06 Polish
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 98% confidence The document text explicitly states that the company ("Spółka") acquired its own shares ("nabyła 942 akcje własne w celu umorzenia"). This action directly relates to the company buying back or repurchasing its own stock. This aligns perfectly with the definition for Transaction in Own Shares (POS), which covers share repurchase/issuance.
2018-04-05 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.